Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form

Pharmaceutical Biology

Volumn 49, Issue 10, 2011, Pages 1039-1045

  Mousavi, Seyed Hadi ^a,b   Moallem, Seyed Adel ^b,c,d   Mehri, Soghra ^c   Shahsavand, Shabnam ^c   Nassirli, Horiyeh ^d   Malaekeh Nikouei, Bizhan ^e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Crocin; Cytotoxicity; Nanoliposome; Saffron

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CROCIN; LIPOSOME; NANOLIPOSOME; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CROCUS SATIVUS; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; ENCAPSULATION; FEMALE; FLOW CYTOMETRY; HELA CELL; HISTOGRAM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAROTENOIDS; CELL SURVIVAL; CROCUS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; EXCIPIENTS; FEMALE; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LIPIDS; LIPOSOMES; MICE; PHOSPHATIDYLCHOLINES; PHYTOTHERAPY; PLANT EXTRACTS; PROPIDIUM; TETRAZOLIUM SALTS; TUMOR CELLS, CULTURED;

CROCUS SATIVUS; IRIDACEAE;

EID: 80053057926     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.563315     Document Type: Article

References (34)

1. Abdullaev FI. (1993). Biological efects of safron. Biofactors, 4, 83-86.
2. Abdullaev FI, Espinosa-Aguirre JJ. (2004). Biomedical properties of safron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev, 28, 426-432. (Pubitemid 39568938)
3. Abe K, Saito H. (2000). Efects of safron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res, 14, 149-152. (Pubitemid 30326004)
4. Andresen TL, Jensen SS, Jørgensen K. (2005). Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specifc drug release. Prog Lipid Res, 44, 68-97. (Pubitemid 40313220)
5. Aung HH, Wang CZ, Ni M, Fishbein A, Mehendale SR, Xie JT, Shoyama CY, Yuan CS. (2007). Crocin from Crocus sativus possesses signifcant anti-proliferation efects on human colorectal cancer cells. Exp Oncol, 29, 175-180. (Pubitemid 350206742)
6. Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, Jia L, Yin HX, Chen C. (2008). Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: a relationship investigation between antioxidant activity and crocin contents. Food Chem, 109, 484-492.
7. Chonn A, Cullis PR. (1995). Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol, 6, 698-708.
8. Chonn A, Cullis PR. (1998). Recent advances in liposome technologies and their applications for systemic gene delivery. Adv Drug Deliv Rev, 30, 73-83. (Pubitemid 28201906)
9. Debatin KM, Poncet D, Kroemer G. (2002). Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene, 21, 8786-8803. (Pubitemid 36132400)
10. Fahr A, Holz M, Fricker G. (1995). Liposomal formulations of cyclosporin A: infuence of lipid type and dose on pharmacokinetics. Pharm Res, 12, 1189-1198.
11. Farokhzad OC, Langer R. (2009). Impact of nanotechnology on drug delivery. ACS Nano, 3, 16-20.
12. Fernndez J-A. (2006). Anticancer properties of safron, Crocus sativus Linn. Adv Phytomed, 2, 313-330.
13. Goyal P, Goyal K, Vijaya Kumar SG, Singh A, Katare OP, Mishra DN. (2005). Liposomal drug delivery systems-clinical applications. Acta Pharm, 55, 1-25. (Pubitemid 40562616)
14. Green DR, Reed JC. (1998). Mitochondria and apoptosis. Science, 281, 1309-1312. (Pubitemid 28406816)
15. He SY, Qian ZY, Tang FT, Wen N, Xu GL, Sheng L. (2005). Efect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sci, 77, 907-921. (Pubitemid 40827194)
16. Hersey P, Zhang XD. (2001). How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer, 1, 142-150. (Pubitemid 33741889)
17. Hosseinzadeh H, Ziaee T, Sadeghi A. (2008). Te efect of safron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine, 15, 491-495. (Pubitemid 351783383)
18. Kamps JAAM, Scherphof GL. (2003). Liposome in biological system. In: Torchilin VP, Weissig V, eds., Liposomes. Oxford, USA: Oxford University Press, pp. 267-301.
19. Kono K, Iwamoto M, Nishikawa R, Yanagie H, Takagishi T. (2000). Design of fusogenic liposomes using a poly(ethylene glycol) derivative having amino groups. J Control Release, 68, 225-235. (Pubitemid 30488900)
20. Kunisawa J, Nakagawa S, Mayumi T. (2001). Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv Drug Deliv Rev, 52, 177-186. (Pubitemid 33097544)
21. Liakopoulou-Kyriakides M, Skubas AI. (1990). Characterization of the platelet aggregation inducer and inhibitor isolated from Crocus sativus. Biochem Int, 22, 103-110. (Pubitemid 20375768)
22. Lv C F, Luo CL, Ji HY, Zhao P. (2008). [Infuence of crocin on gene expression profle of human bladder cancer cell lines T24]. Zhongguo Zhong Yao Za Zhi, 33, 1612-1617.
23. Malaekeh-Nikouei B, Davies N. (2009). Double loading of cyclosporine A in liposomes using cyclodextrin complexes. PDA J Pharm Sci Technol, 63, 139-148.
24. Malaekeh-Nikouei B, Jaafari MR, Tabassi SA, Samiei A. (2008). Te enhancement of immunosuppressive efects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids Surf B Biointerfaces, 67, 238-244.
25. Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I. (2009). Role of caspases and Bax protein in safron-induced apoptosis in MCF-7 cells. Food Chem Toxicol, 47, 1909-1913.
26. Pagano RE, Weinstein JN. (1978). Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng, 7, 435-468.
27. Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. (2008). Efects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine, 15, 1135-1139.
28. Sheng L, Qian Z, Zheng S, Xi L. (2006). Mechanism of hypolipidemic efect of crocin in rats: crocin inhibits pancreatic lipase. Eur J Pharmacol, 543, 116-122. (Pubitemid 44092692)
29. Tavakkol-Afshari J, Brook A, Mousavi SH. (2008). Study of cytotoxic and apoptogenic properties of safron extract in human cancer cell lines. Food Chem Toxicol, 46, 3443-3447.
30. Torchilin V P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 4, 145-160. (Pubitemid 40282557)
31. Tripathi YB, Tripathi P, Arjmandi BH. (2005). Nutraceuticals and cancer management. Front Biosci, 10, 1607-1618. (Pubitemid 40532952)
32. Zhang XD, Gillespie SK, Hersey P. (2004). Staurosporine induces apoptosis of melanoma by both caspase-dependent and-independent apoptotic pathways. Mol Cancer Ter, 3, 187-197. (Pubitemid 39193693)
33. Zhao P, Luo CL, Wu XH, Hu HB, Lv CF, Ji HY. (2008). [Proliferation apoptotic infuence of crocin on human bladder cancer T24 cell line]. Zhongguo Zhong Yao Za Zhi, 33, 1869-1873.
34. Zheng YQ, Liu JX, Wang JN, Xu L. (2007). Efects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res, 1138, 86-94.